Experienced in Ewing Sarcoma

Dr. David H. Ebb

Pediatrics
55 Fruit St, Yaw 8b, Pediatric Hematolgy-oncology, 
Boston, MA 

Experienced in Ewing Sarcoma
55 Fruit St, Yaw 8b, Pediatric Hematolgy-oncology, 
Boston, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

David Ebb is a Pediatrics provider in Boston, Massachusetts. Dr. Ebb is rated as an Experienced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Medulloblastoma, Glioma, Embryonal Tumor with Multilayered Rosettes, and Osteosarcoma.

His clinical research consists of co-authoring 60 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Ewing Sarcoma.

Graduate Institution
S.U.N.Y. At Stony Brook, 1983 - 1987
Residency
Montefiore Hospital & Medical Center, 1987 - 1990
Specialties
Pediatrics
Licenses
Pediatrics in MA
Board Certifications
Pediatrics
Pediatric Hematology-Oncology
Fellowships
Children's National Medical Center, 1990 - 1993
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Neighborhood
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

55 Fruit St, Yaw 8b, Pediatric Hematolgy-oncology, Boston, MA 02114
Call: 617-726-2737

Additional Areas of Focus

Dr. Ebb has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Phase 2 Study of Dabrafenib (NSC# 763760) With Trametinib (NSC# 763093) After Local Irradiation in Newly-Diagnosed BRAF V600-Mutant High-Grade Glioma (HGG)
A Phase 2 Study of Dabrafenib (NSC# 763760) With Trametinib (NSC# 763093) After Local Irradiation in Newly-Diagnosed BRAF V600-Mutant High-Grade Glioma (HGG)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Radiation, Drug
Study Drugs: Dabrafenib Mesylate, Trametinib Dimethyl Sulfoxide
Study Phase: Phase 2
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
A Phase 3 Randomized Study of Selumetinib Versus Carboplatin/Vincristine in Newly Diagnosed or Previously Untreated Neurofibromatosis Type 1 (NF1) Associated Low-Grade Glioma (LGG)
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure, Drug
Study Drugs: Carboplatin, Selumetinib Sulfate, Vincristine Sulfate
Study Phase: Phase 3
A Safety, Pharmacokinetic and Efficacy Study of a y-Secretase Inhibitor, Nirogacestat (PF-03084014), in Children and Adolescents With Progressive, Surgically Unresectable Desmoid Tumors
A Safety, Pharmacokinetic and Efficacy Study of a y-Secretase Inhibitor, Nirogacestat (PF-03084014), in Children and Adolescents With Progressive, Surgically Unresectable Desmoid Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 02, 2026
Intervention Type: Other, Procedure, Drug
Study Drug: Nirogacestat
Study Phase: Phase 2
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Enrollment Status: Active_not_recruiting
Publish Date: December 22, 2025
Intervention Type: Drug, Procedure, Radiation, Other
Study Drugs: Cisplatin, Cyclophosphamide, Lomustine, Vincristine, Vincristine Sulfate
Study Phase: Phase 2
A Target Validation/Phase1 Study of BGB-290 in Combination With Temozolomide in Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas
A Target Validation/Phase1 Study of BGB-290 in Combination With Temozolomide in Adolescent and Young Adult IDH1/2 Newly Diagnosed and Recurrent Mutant Gliomas
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drugs: BGB-290, Temozolomide
Study Phase: Phase 1
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Enrollment Status: Active_not_recruiting
Publish Date: October 27, 2025
Intervention Type: Drug, Radiation, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Vincristine
Study Phase: Phase 3
A Phase I Study of Tovorafenib/DAY101 (Formerly TAK-580, MLN2480) for Children With Low-Grade Gliomas and Other RAS/RAF/MEK/ERK Pathway Activated Tumors
A Phase I Study of Tovorafenib/DAY101 (Formerly TAK-580, MLN2480) for Children With Low-Grade Gliomas and Other RAS/RAF/MEK/ERK Pathway Activated Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 03, 2025
Intervention Type: Drug
Study Drug: DAY101
Study Phase: Phase 1
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Enrollment Status: Completed
Publish Date: October 03, 2024
Intervention Type: Drug
Study Drug: Tazemetostat
Study Phase: Phase 1
View 7 Less Clinical Trials

60 Total Publications

Quality of life in pediatric patients treated with adjuvant proton radiation for craniopharyngiomas.
Quality of life in pediatric patients treated with adjuvant proton radiation for craniopharyngiomas.
Journal: Journal of neuro-oncology
Published: March 27, 2025
View All 60 Publications
Similar Doctors
Advanced in Ewing Sarcoma
Dr. Suzanne Shusterman
Pediatrics
Advanced in Ewing Sarcoma
Dr. Suzanne Shusterman
Pediatrics

Dana-Farber/Boston Children's Cancer And Blood Disorders Center

450 Brookline Avenue, 
Boston, MA 
 (2.7 miles away)
617-632-4901
Languages Spoken:
English
See accepted insurances

Suzanne Shusterman is a Pediatrics provider in Boston, Massachusetts. Dr. Shusterman is rated as a Distinguished provider by MediFind in the treatment of Ewing Sarcoma. Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hereditary Neuroblastoma, Osteosarcoma, and Bone Marrow Aspiration.

Experienced in Ewing Sarcoma
Dr. David S. Shulman
Oncology | Pediatrics
Experienced in Ewing Sarcoma
Dr. David S. Shulman
Oncology | Pediatrics

Dana-Farber Cancer Institute, Sarcoma And Bone Cancer Treatment Center

450 Brookline Avenue, 
Boston, MA 
 (2.7 miles away)
617-919-3041
Languages Spoken:
English
See accepted insurances

David Shulman is an Oncologist and a Pediatrics provider in Boston, Massachusetts. Dr. Shulman is rated as an Experienced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Neuroblastoma, Hereditary Neuroblastoma, Osteosarcoma, and Ewing Sarcoma.

Experienced in Ewing Sarcoma
Dr. Alex Kentsis
Pediatrics | Hematology | Oncology
Experienced in Ewing Sarcoma
Dr. Alex Kentsis
Pediatrics | Hematology | Oncology
450 Brookline Ave, 
Boston, MA 
 (2.7 miles away)
617-632-4130
Languages Spoken:
English
See accepted insurances

Alex Kentsis is a Pediatrics specialist and a Hematologist in Boston, Massachusetts. Dr. Kentsis is rated as a Distinguished provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Rhabdoid Tumor, Familial Wilms Tumor 2, Wilms Tumor, and Leukemia.

VIEW MORE EWING SARCOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ebb's expertise for a condition
ConditionClose
    • Distinguished
    • Medulloblastoma
      Dr. Ebb is
      Distinguished
      . Learn about Medulloblastoma.
      See more Medulloblastoma experts
    • Advanced
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Ebb is
      Advanced
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    • Glioma
      Dr. Ebb is
      Advanced
      . Learn about Glioma.
      See more Glioma experts
    • Osteosarcoma
      Dr. Ebb is
      Advanced
      . Learn about Osteosarcoma.
      See more Osteosarcoma experts
    • Experienced
    • Adult Soft Tissue Sarcoma
      Dr. Ebb is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Ewing Sarcoma
      Dr. Ebb is
      Experienced
      . Learn about Ewing Sarcoma.
      See more Ewing Sarcoma experts
    • Infantile Neutropenia
      Dr. Ebb is
      Experienced
      . Learn about Infantile Neutropenia.
      See more Infantile Neutropenia experts
    • Neuroblastoma
      Dr. Ebb is
      Experienced
      . Learn about Neuroblastoma.
      See more Neuroblastoma experts
    • Pediatric Low-Grade Glioma (pLGG)
      Dr. Ebb is
      Experienced
      . Learn about Pediatric Low-Grade Glioma (pLGG).
      See more Pediatric Low-Grade Glioma (pLGG) experts
    • Rhabdomyosarcoma
      Dr. Ebb is
      Experienced
      . Learn about Rhabdomyosarcoma.
      See more Rhabdomyosarcoma experts
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.